Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Cancer Research|November 17, 2005
Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumorsHafid Alazzouzi, Veronica Davalos, Antti Kokko, et al.
Nature Communications|March 11, 2020
TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adductsJohn Fielden, Katherine Wiseman, Ignacio Torrecilla, et al.
Genome Medicine|May 26, 2017
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1Anita Sveen, Bjarne Johannessen, Torstein Tengs, et al.
The Journal of Pathology|November 21, 2012
Use of multivariate analysis to suggest a new molecular classification of colorectal cancerEnric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, et al.
Molecular Systems Biology|November 5, 2017
Pharmacoproteomic characterisation of human colon and rectal cancerMartin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, et al.
NPJ Precision Oncology|October 14, 2022
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapyLiam F Spurr, Carlos A Martinez, Rohan R Katipally, et al.
International Journal of Cardiology|April 26, 2022
Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stentImanol Otaegui Irurueta, Silvia González Sucarrats, Jose Luis Barrón Molina, et al.
NPJ Precision Oncology|April 9, 2024
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapyMaxime W Lafarge, Enric Domingo, Korsuk Sirinukunwattana, et al.
Cell Reports. Medicine|September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancerMarta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
Translational Oncology|February 7, 2026
CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancerVenkatesh Rajamanickam, Noah D Simons, Wesley Rosales, et al.
Pageof 12